Emcure Pharmaceuticals files FY26 sustainability report with stock exchanges
- Emcure Pharmaceuticals filed its FY26 BRSR report with stock exchanges on August 28, 2026
- Total energy consumption rose to 738,954.5 GJ, but energy intensity improved to 14.09 per rupee of turnover
- Scope 2 emissions fell to 46,458.97 tCO2e, while Scope 1 emissions increased to 30,082.43 tCO2e
- Waste generation jumped to 6,255.97 MT, with recycling recovery rising to 3,459.81 MT
- Related party sales accounted for 36% of total turnover, up from 32% in the prior year
*this image is generated using AI for illustrative purposes only.
Emcure Pharmaceuticals submitted its Business Responsibility and Sustainability Report (BRSR) for the financial year ending March 31, 2026, to the National Stock Exchange of India Limited and BSE Limited on August 28, 2026.
The disclosure was made pursuant to Regulation 34(2)(f) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The report forms an integral part of the company’s annual report for FY26 and is available on its corporate website.
Environmental Performance
The company reported a total energy consumption of 738,954.5369 GJ for FY26, an increase from 682,465.48405 GJ in the previous fiscal year. Renewable energy sources accounted for 477,828.8027 GJ of this total, while non-renewable sources contributed 261,125.7342 GJ. Energy intensity per rupee of turnover decreased to 14.09 from 15.57 in FY25.
Water consumption stood at 549,171.94 kilolitres, up from 510,736.01 kilolitres in FY25. Water intensity per rupee of turnover improved to 10.47 from 11.66. The company discharged only 140 kilolitres of water, compared to 10 kilolitres in the prior year, with all discharges sent to third parties without treatment.
Greenhouse gas emissions showed mixed trends. Scope 1 emissions rose to 30,082.433 tCO2e from 27,257.03 tCO2e. However, Scope 2 emissions declined to 46,458.97 tCO2e from 50,784.63 tCO2e. The combined emission intensity per rupee of turnover fell to 1.46 tCO2e/INR Mn from 1.78 tCO2e/INR Mn.
Waste Management
Total waste generated increased to 6,255.97 metric tonnes from 4,203.32 metric tonnes in FY25. Hazardous waste constituted the majority at 4,438.74 metric tonnes. The company recycled or recovered 3,459.81 metric tonnes of waste, a significant rise from 1,876.97 metric tonnes in the previous year. Waste disposed of via incineration and landfilling totaled 1,092.12 metric tonnes.
Employee Safety and Wellbeing
The workforce comprised 6,667 employees and 2,930 workers as of March 31, 2026. Female representation among permanent employees remained at 9%. The company reported three recordable work-related injuries: two involving employees and one involving workers. No fatalities were recorded. The Lost Time Injury Frequency Rate (LTIFR) was 0.805 for employees and 0.475 for workers.
Spending on employee wellbeing measures accounted for 0.13% of total revenue, down from 0.15% in FY25. All permanent employees and workers were covered by health and accident insurance.
Governance and Related Party Transactions
The report highlighted significant related party transaction exposure. Sales to related parties constituted 36% of total sales, up from 32% in FY25. Investments in related parties made up 98% of total investments. Purchases from related parties remained low at 3% of total purchases.
TÜV Rheinland India Pvt Ltd provided reasonable assurance for the BRSR core indicators and limited assurance for other disclosures. The assurance covered nine manufacturing sites and one corporate office across India.
Historical Stock Returns for Emcure Pharmaceuticals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.27% | +1.54% | +7.19% | +31.20% | +49.85% | +47.84% |
How will Emcure's increasing reliance on related party transactions (now 36% of sales) impact investor confidence regarding operational independence and potential conflict of interest risks?
Given the rise in total energy consumption and Scope 1 emissions, what specific capital expenditures or technological upgrades is Emcure planning to implement to meet India's stricter environmental regulations in the coming fiscal years?
With hazardous waste generation increasing significantly to 4,438.74 metric tonnes, what long-term strategies is the company adopting to reduce waste at the source rather than relying solely on recycling and recovery?
20
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
